Regulation, Reduction, and ROI with Clarity LIMS | GenomeWeb
January 21, 2015
Sponsored by
GenoLogics

Regulation, Reduction, and ROI with Clarity LIMS

Partner Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This on-demand seminar, recorded in late 2014, describes how omics labs can use Clarity LIMS to achieve or maintain regulatory status, reduce sample turnaround time and errors, and streamline all lab operations.
 
Jill Hesse, Field Application Specialist at GenoLogics, provides context and then takes viewers on an informational tour of Clarity LIMS in this online seminar
Sponsored by

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.